Cargando…
Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate
BACKGROUND: Proton pump inhibitors (PPIs) are often the first drug of choice in the treatment of eosinophilic oesophagitis (EoE), and in Denmark 8 weeks of high‐dose PPI therapy is recommended as first‐line treatment followed by rebiopsying, reflecting international recommendations. AIMS: To assess...
Autores principales: | Frandsen, Line Tegtmeier, Westmark, Signe, Melgaard, Dorte, Krarup, Anne Lund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498393/ https://www.ncbi.nlm.nih.gov/pubmed/34477326 http://dx.doi.org/10.1002/ueg2.12146 |
Ejemplares similares
-
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 2018
por: Allin, Kristine Højgaard, et al.
Publicado: (2022) -
A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education ‐ a population‐based cross‐sectional study of incidence, diagnostic process and complications of eosinophilic oesophagitis in the North Denmark Region
por: Melgaard, Dorte, et al.
Publicado: (2021) -
The phenotype of adults with complicated eosinophilic esophagitis is dominated by a 5‐year longer diagnostic delay: A population‐based study of the DanEoE cohort
por: Henriksen, Stine D, et al.
Publicado: (2023) -
Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry
por: Navarro, Pilar, et al.
Publicado: (2022) -
Incidence and prevalence of eosinophilic oesophagitis: Are we reaching a plateau?
por: Masclee, Gwen M. C., et al.
Publicado: (2022)